Pharmaceuticals Ultrasector Valuation
| PHPIX Fund | USD 27.85 0.48 1.75% |
At this time, the fund appears to be fairly valued. Pharmaceuticals Ultrasector holds a recent Real Value of $27.79 per share. The prevailing price of the fund is $27.85. We determine the value of Pharmaceuticals Ultrasector from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we support acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will merge together.
Fairly Valued
Today
Please note that Pharmaceuticals Ultrasector's price fluctuation is very steady at this time. At this time, the fund appears to be fairly valued. Pharmaceuticals Ultrasector holds a recent Real Value of $27.79 per share. The prevailing price of the fund is $27.85. We determine the value of Pharmaceuticals Ultrasector from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we support acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will merge together.
Since Pharmaceuticals Ultrasector is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Pharmaceuticals Mutual Fund. However, Pharmaceuticals Ultrasector's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 27.85 | Real 27.79 | Hype 27.85 |
The intrinsic value of Pharmaceuticals Ultrasector's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Pharmaceuticals Ultrasector's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Pharmaceuticals Ultrasector Profund helps investors to forecast how Pharmaceuticals mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pharmaceuticals Ultrasector more accurately as focusing exclusively on Pharmaceuticals Ultrasector's fundamentals will not take into account other important factors: Pharmaceuticals Ultrasector Total Value Analysis
Pharmaceuticals Ultrasector Profund is at this time forecasted to have takeover price of 0 with market capitalization of 0, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Pharmaceuticals Ultrasector fundamentals before making investing decisions based on enterprise value of the companyPharmaceuticals Ultrasector Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Pharmaceuticals suggests not a very effective usage of assets in December.About Pharmaceuticals Ultrasector Valuation
Our relative valuation model uses a comparative analysis of Pharmaceuticals Ultrasector. We calculate exposure to Pharmaceuticals Ultrasector's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Pharmaceuticals Ultrasector's related companies.The fund invests in financial instruments that the fund Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index represents the pharmaceuticals segment of the SP Total Market Index, which comprises the following sub-industry pharmaceuticals. The fund is non-diversified.
Other Information on Investing in Pharmaceuticals Mutual Fund
Pharmaceuticals Ultrasector financial ratios help investors to determine whether Pharmaceuticals Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmaceuticals with respect to the benefits of owning Pharmaceuticals Ultrasector security.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| CEOs Directory Screen CEOs from public companies around the world |